SBC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
49.2M
+14.2%
43.1M
+8.8%
39.6M
-8.7%
43.4M
-0.0%
43.4M
Cost of Revenue
13.2M
+3.9%
12.7M
+19.5%
10.6M
-16.5%
12.7M
-4.5%
13.3M
Gross Profit
36.0M
+18.6%
30.3M
+4.9%
28.9M
-5.5%
30.6M
+2.0%
30.0M
Operating Expenses
17.0M
+34.8%
12.6M
-21.5%
16.1M
+9.2%
14.7M
-4.7%
15.5M
R&D
0
0
0
0
0
SG&A
17.0M
+34.8%
12.6M
-21.5%
16.1M
+9.2%
14.7M
-4.7%
15.5M
Operating Income
19.0M
+7.0%
17.7M
+37.9%
12.8M
-19.1%
15.9M
+9.1%
14.6M
EBITDA
20.1M
+9.3%
18.4M
+36.0%
13.5M
-18.7%
16.6M
+9.5%
15.2M
Net Income
11.2M
-1.5%
11.3M
-20.7%
14.3M
+11.3%
12.8M
+426.0%
2.4M
EPS (Basic)
$0.10
-9.1%
$0.11
-21.4%
$0.14
+16.7%
$0.12
+500.0%
$0.02
EPS (Diluted)
$0.10
-9.1%
$0.11
-21.4%
$0.14
+16.7%
$0.12
+500.0%
$0.02
Shares (Diluted)
102.6M
+0.0%
102.6M
+0.0%
102.6M
-0.1%
102.6M
-0.8%
103.5M
SBC Medical (SBC) โ€” Financials